Announced Wed, 15 Jul · 15:31 IST

Biocon 48th AGM notice and Integrated Annual Report FY26 with BRSR and ESG Data Book

Board & Shareholder Meetings View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.5%1-day move

₹434.35

prior close

₹438.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.7-0.7-0.8-0.1+0.5+0.4+1.4+0.9+0.6+0.6————

Up moveDown movePending

AI summary

Biocon filed its 48th AGM notice (Aug 6, 2026 via VC) along with Integrated Annual Report FY26 including BRSR and ESG Data Book. FY26 total income rose 14% to about INR 17,270 crore (USD 1.96 billion), EBITDA grew 25% to INR 3,798 crore. Profit stood at INR 386 crore, EPS INR 2.82. Final dividend of INR 0.50 per share declared, record date July 3, payment by Aug 20. Biocon Biologics fully integrated. New CEO Shreehas Tambe. Biosimilars grew 16%, 12 products now commercialized globally.

Likely market impact

AGM on Aug 6, final dividend INR 0.50 per share, record date July 3. Strong FY26 with revenue up 14% and EBITDA up 25%, biologics fully integrated.